Other languages Imugene Limited

Equities

IMU

AU000000IMU9

Market Closed - Australian S.E. Other stock markets 02:10:46 2024-04-30 am EDT			5-day change	1st Jan Change
0.087 ^AUD	+6.10%		+2.35%	-20.91%

Apr. 16	Imugene Signs Deal to Sell Manufacturing Facility For $6 Million	MT
Apr. 16	Kincell Bio, LLC signed an asset purchase agreement to acquire North Carolina manufacturing facility from Imugene Limited for $6 million.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Imugene Limited Announce Enrolment Opened for Its Expansion Study in Bile Tract Cancer (Cholangiocarcinoma) Patients	Apr. 15
Imugene Secures Patent for Oncolytic Virotherapy CF33 in China	Apr. 03
Arovella Therapeutics' ALA-101-onCARlytics Collaboration with Imugene Ends; Shares Down 12%	Mar. 19
Imugene Limited Announces Phase 1 onCARlytics Solid Tumour Trial Advances to Combination Arm Treatment	Mar. 11
Imugene's Phase 1 onCARlytics Trial to Commence Combination Arm Treatment	Mar. 10
Imugene Widens Per-Share Loss in H1 FY24 to AU$0.01 on Higher General, R&D Spending	Feb. 28
Imugene Reports H1 FY24 Loss Widens as Expenses Grow	Feb. 28
Imugene Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 28
Imugene’s Phase 1 onCARlytics Trial Doses First Patient in Intravenous Monotherapy Arm	Feb. 14
Esken's Southend Airport faces further allegations	Jan. 23
MaxCyte Inks Platform License Deal With Cancer Medicine Developer Imugene	Jan. 23
Australian Shares End Five-Day Losing Streak Amid Market Conviction of Early US Fed Pivot	Jan. 19
Imugene’s VAXINIA Metastatic Advanced Solid Tumors Trial Doses First Patients in Higher Dose Cohorts; Shares Up 10%	Jan. 18
Imugene's Vaxinia Trial Shows Positive Signs	Jan. 18
Imugene to Open Phase Two Colorectal Cancer Trial in the UK, Australia	Dec. 06
Imugene to Secure European Patent for Cancer Vaccine	Dec. 05
FDA Grants Fast Track Designation for Imugene's CF33-hNIS in Bile Duct Cancer MAST Program	Nov. 28
US FDA Transfers Cancer Medication Application to Imugene	23-09-28
Imugene Raises AU$18 Million in Share Purchase Plan	23-09-25
MÄRKTE ASIEN/Tokio fester und Seoul leichter - Sonst wenig Bewegung	23-09-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Imugene Limited

Equities

IMU

AU000000IMU9

Other languages

Filters